259 related articles for article (PubMed ID: 22823162)
1. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.
Tan AC; Mifsud EJ; Zeng W; Edenborough K; McVernon J; Brown LE; Jackson DC
Mol Pharm; 2012 Sep; 9(9):2710-8. PubMed ID: 22823162
[TBL] [Abstract][Full Text] [Related]
2. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice.
Abdul-Careem MF; Firoz Mian M; Gillgrass AE; Chenoweth MJ; Barra NG; Chan T; Al-Garawi AA; Chew MV; Yue G; van Roojen N; Xing Z; Ashkar AA
Antiviral Res; 2011 Nov; 92(2):346-55. PubMed ID: 21945041
[TBL] [Abstract][Full Text] [Related]
3. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
4. Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract.
Marois I; Cloutier A; Garneau É; Richter MV
J Leukoc Biol; 2012 Jul; 92(1):107-21. PubMed ID: 22504848
[TBL] [Abstract][Full Text] [Related]
5. Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.
Mifsud EJ; Tan AC; Reading PC; Jackson DC
Immunol Cell Biol; 2016 Feb; 94(2):169-76. PubMed ID: 26272554
[TBL] [Abstract][Full Text] [Related]
6. Nasal mucosal administration of chitin microparticles boosts innate immunity against influenza A virus in the local pulmonary tissue.
Baaten BJ; Clarke B; Strong P; Hou S
Vaccine; 2010 Jun; 28(25):4130-7. PubMed ID: 20433805
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus.
Ichinohe T; Nagata N; Strong P; Tamura S; Takahashi H; Ninomiya A; Imai M; Odagiri T; Tashiro M; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2007 Jun; 79(6):811-9. PubMed ID: 17457919
[TBL] [Abstract][Full Text] [Related]
8. Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope.
Tan AC; Eriksson EM; Kedzierska K; Deliyannis G; Valkenburg SA; Zeng W; Jackson DC
Antiviral Res; 2012 May; 94(2):168-78. PubMed ID: 22504097
[TBL] [Abstract][Full Text] [Related]
9. The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus.
Suda T; Kawano M; Nogi Y; Ohno N; Akatsuka T; Matsui M
Antiviral Res; 2011 Sep; 91(3):252-8. PubMed ID: 21722671
[TBL] [Abstract][Full Text] [Related]
10. Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.
Dessing MC; van der Sluijs KF; Florquin S; van der Poll T
Clin Immunol; 2007 Dec; 125(3):328-36. PubMed ID: 17827068
[TBL] [Abstract][Full Text] [Related]
11. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.
Garulli B; Meola M; Stillitano MG; Kawaoka Y; Castrucci MR
Virology; 2007 May; 361(2):274-82. PubMed ID: 17222437
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the immune-related gene responses to protect mice against Japanese encephalitis virus using the antimicrobial peptide, tilapia hepcidin 1-5.
Huang HN; Rajanbabu V; Pan CY; Chan YL; Hui CF; Chen JY; Wu CJ
Biomaterials; 2011 Oct; 32(28):6804-14. PubMed ID: 21726898
[TBL] [Abstract][Full Text] [Related]
13. 17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.
Robinson DP; Hall OJ; Nilles TL; Bream JH; Klein SL
J Virol; 2014 May; 88(9):4711-20. PubMed ID: 24522912
[TBL] [Abstract][Full Text] [Related]
14. Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
Stevenson PG; Hawke S; Bangham CR
J Immunol; 1996 Oct; 157(7):3065-73. PubMed ID: 8816416
[TBL] [Abstract][Full Text] [Related]
15. Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza.
Cobbin JC; Zeng W; Jackson DC; Brown LE
PLoS One; 2014; 9(12):e115356. PubMed ID: 25522323
[TBL] [Abstract][Full Text] [Related]
16. The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity.
Marois I; Cloutier A; Garneau É; Lesur O; Richter MV
FASEB J; 2015 Mar; 29(3):973-87. PubMed ID: 25414485
[TBL] [Abstract][Full Text] [Related]
17. Resistance to mycobacterial infection: a pattern of early immune responses leads to a better control of pulmonary infection in C57BL/6 compared with BALB/c mice.
Arko-Mensah J; Rahman MJ; Dégano IR; Chuquimia OD; Fotio AL; Garcia I; Fernández C
Vaccine; 2009 Dec; 27(52):7418-27. PubMed ID: 19735756
[TBL] [Abstract][Full Text] [Related]
18. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
Cerwenka A; Morgan TM; Dutton RW
J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
[TBL] [Abstract][Full Text] [Related]
19. LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice.
Sedgmen BJ; Dawicki W; Gommerman JL; Pfeffer K; Watts TH
Int Immunol; 2006 May; 18(5):797-806. PubMed ID: 16569673
[TBL] [Abstract][Full Text] [Related]
20. Prior exposure to acrolein accelerates pulmonary inflammation in influenza A-infected mice.
Ong FH; Henry PJ; Burcham PC
Toxicol Lett; 2012 Aug; 212(3):241-51. PubMed ID: 22705057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
